These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33272732)

  • 1. A delicate compromise: Striking a balance between public safety measures and the psychosocial needs of staff and clients in residential substance use disorder treatment amid COVID-19.
    Herrera A
    J Subst Abuse Treat; 2021 Mar; 122():108208. PubMed ID: 33272732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of COVID-19 on residential treatment programs for substance use disorder.
    Pagano A; Hosakote S; Kapiteni K; Straus ER; Wong J; Guydish JR
    J Subst Abuse Treat; 2021 Apr; 123():108255. PubMed ID: 33375986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VA residential substance use disorder treatment program providers' perceptions of facilitators and barriers to performance on pre-admission processes.
    Ellerbe LS; Manfredi L; Gupta S; Phelps TE; Bowe TR; Rubinsky AD; Burden JL; Harris AH
    Addict Sci Clin Pract; 2017 Apr; 12(1):10. PubMed ID: 28372579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitigation of Covid-19 infection in substance use disorder residential settings.
    Fareed A; Fareed M
    J Addict Dis; 2021; 39(1):140-143. PubMed ID: 33036545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs.
    Masson CL; McCuistian C; Straus E; Elahi S; Chen M; Gruber VA; Le T; Guydish J
    Drug Alcohol Depend; 2021 Aug; 225():108812. PubMed ID: 34174773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical Dilemmas Facing Substance Use Counselors During the COVID-19 Pandemic.
    McCuistian C; Fokuo JK; Dumoit Smith J; Sorensen JL; Arnold EA
    Subst Abuse; 2023; 17():11782218231158338. PubMed ID: 36923068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moment-by-Moment in Women's Recovery (MMWR): Mindfulness-based intervention effects on residential substance use disorder treatment retention in a randomized controlled trial.
    Black DS; Amaro H
    Behav Res Ther; 2019 Sep; 120():103437. PubMed ID: 31419610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient continuing care after residential substance use disorder treatment in the US Veterans Health Administration: Facilitators and challenges.
    Rubinsky AD; Ellerbe LS; Gupta S; Phelps TE; Bowe T; Burden JL; Harris AHS
    Subst Abus; 2018; 39(3):322-330. PubMed ID: 29043947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing clinical impacts and attitudes related to COVID-19 among residential substance use disorder patients.
    Wildberger J; Wenzel K; Fishman M
    Subst Abus; 2022; 43(1):756-762. PubMed ID: 35112980
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and psychological impact of sailing adventure therapy among Veterans with substance use disorders.
    Marchand WR; Klinger W; Block K; VerMerris S; Herrmann TS; Johnson C; Shubin E; Sheppard S
    Complement Ther Med; 2018 Oct; 40():42-47. PubMed ID: 30219467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking and Tobacco-Free Policies in Women's Residential Substance Use Disorder Treatment Facilities: A Community-Engaged Approach.
    Fallin-Bennett A; Parker KA; Miller A; Ashford K; Hahn EJ
    Nicotine Tob Res; 2018 Sep; 20(11):1386-1392. PubMed ID: 29059449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of engagement in continuing care following residential substance use disorder treatment.
    Harris AH; McKellar JD; Moos RH; Schaefer JA; Cronkite RC
    Drug Alcohol Depend; 2006 Sep; 84(1):93-101. PubMed ID: 16417977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Health professionals facing the coronavirus disease 2019 (COVID-19) pandemic: What are the mental health risks?].
    El-Hage W; Hingray C; Lemogne C; Yrondi A; Brunault P; Bienvenu T; Etain B; Paquet C; Gohier B; Bennabi D; Birmes P; Sauvaget A; Fakra E; Prieto N; Bulteau S; Vidailhet P; Camus V; Leboyer M; Krebs MO; Aouizerate B
    Encephale; 2020 Jun; 46(3S):S73-S80. PubMed ID: 32370984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Covid-19 Infection and Subsequent Cohorting in a Residential Substance Use Treatment Program in Boston, MA.
    Barocas JA; Blackstone E; Bouton TC; Kimmel SD; Caputo A; Porter SJ; Walley AY
    J Addict Med; 2020; 14(5):e261-e263. PubMed ID: 32530889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 broken access: implications for individuals with substance use disorders.
    Estreet AT; Archibald P; Price L
    Soc Work Public Health; 2022 Nov; 37(8):763-774. PubMed ID: 35895496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental Health and Quality & Safety of Care in Czech Residential Institutions during the COVID-19 Pandemic: A Mixed-Methods Study.
    Guerrero Z; Aliev AA; Kondrátová L; Jozefiaková B; Nesázalová N; Saňáková JG; Winkler P
    Psychiatr Q; 2021 Dec; 92(4):1393-1411. PubMed ID: 33821407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of implementing a tobacco and recreational nicotine-free policy and enhanced treatments on programmatic and patient-level outcomes within a residential substance use disorder treatment program.
    Hemmy Asamsama O; Miller SC; Silvestri MM; Bonanno C; Krondilou K
    J Subst Abuse Treat; 2019 Dec; 107():44-49. PubMed ID: 31757264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance use treatment in Appalachian Tennessee amid COVID-19: Challenges and preparing for the future.
    Kedia SK; Schmidt M; Dillon PJ; Arshad H; Yu X
    J Subst Abuse Treat; 2021 May; 124():108270. PubMed ID: 33771275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities in outpatient visits for mental health and/or substance use disorders during the COVID surge and partial reopening in Massachusetts.
    Yang J; Landrum MB; Zhou L; Busch AB
    Gen Hosp Psychiatry; 2020; 67():100-106. PubMed ID: 33091782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using qualitative, community-based input to steer post-coronavirus disease 2019 pharmacy practice in substance use.
    Kosobuski L; Hawn A; France K; Chen N; LaPlante C; Palombi L
    J Am Pharm Assoc (2003); 2022; 62(5):1555-1563.e2. PubMed ID: 35428578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.